UNSPSC 51172450: Bismuth/kaolin/opium/pectin/potassium/salol/zinc

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA208. This VA Drug Class (GA208) classifies this compound as belonging to the group ANTIDIARRHEAL AGENTS.

UNSPSC 51172450 Bismuth/kaolin/opium/pectin/potassium/salol/zinc is a Commodity code that shows minimal alignment between its nominal scope and recent state and local procurement activity. The three most recent solicitations posted under this code cover offender drug testing services, pharmacy benefit management, and generic pharmaceutical supply — none of which involve the specialized chemical compounds or mineral products the code name describes. The mismatch suggests either systematic miscoding in state and local procurement systems or that the code is being used as a catch-all for pharmaceutical and diagnostic-related goods without regard to its intended chemical taxonomy. State and local issuing bodies treating the code as relevant include a county correctional department (Collin County, Texas), a state health commission (Texas HHS), and a multistate cooperative purchasing alliance (MMCAP, administered through Minnesota).

Recent activity concentrates in Texas and the Upper Midwest. Collin County Community Supervision and Corrections Department posted RFP 2026-327 for offender specimen collection and drug testing services with a response deadline of July 23, 2026, seeking immunoassay screening and LC/MS/MS or GC/MS confirmation across two sites with an estimated contract value of $600,000 over two years plus three optional one-year renewals. The Texas Health and Human Services Commission issued RFI HHS0017013 on March 27, 2026 (response due April 3, 2026) to gather market intelligence on direct-to-manufacturer pharmacy benefit programs without committed budget or timeline. MMCAP, a multistate cooperative purchasing vehicle administered by Minnesota, issued RFP S1070000015802 due March 26, 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities including Oregon, with contracts effective July 1, 2026 and a two-year initial term. No relevant pharmaceutical or diagnostic chemical procurement activity appears under the code's stated commodity scope.